As of January 1, 2024, 12 percent of Alzheimer’s disease drugs in clinical trial phase II of development worldwide were targeting synaptic plasticity/neuroprotection pathways. This statistic illustrates Alzheimer’s disease therapies in phase II of development worldwide, by type.
Alzheimer’s disease drugs in clinical trial phase II worldwide as of 2024, by type
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Alzheimer's Association. (April 24, 2024). Alzheimer’s disease drugs in clinical trial phase II worldwide as of 2024, by type [Graph]. In Statista. Retrieved December 19, 2024, from https://www.statista.com/statistics/1173714/alzheimer-disease-therapies-in-phase-ii-by-type/
Alzheimer's Association. "Alzheimer’s disease drugs in clinical trial phase II worldwide as of 2024, by type." Chart. April 24, 2024. Statista. Accessed December 19, 2024. https://www.statista.com/statistics/1173714/alzheimer-disease-therapies-in-phase-ii-by-type/
Alzheimer's Association. (2024). Alzheimer’s disease drugs in clinical trial phase II worldwide as of 2024, by type. Statista. Statista Inc.. Accessed: December 19, 2024. https://www.statista.com/statistics/1173714/alzheimer-disease-therapies-in-phase-ii-by-type/
Alzheimer's Association. "Alzheimer’s Disease Drugs in Clinical Trial Phase Ii Worldwide as of 2024, by Type." Statista, Statista Inc., 24 Apr 2024, https://www.statista.com/statistics/1173714/alzheimer-disease-therapies-in-phase-ii-by-type/
Alzheimer's Association, Alzheimer’s disease drugs in clinical trial phase II worldwide as of 2024, by type Statista, https://www.statista.com/statistics/1173714/alzheimer-disease-therapies-in-phase-ii-by-type/ (last visited December 19, 2024)
Alzheimer’s disease drugs in clinical trial phase II worldwide as of 2024, by type [Graph], Alzheimer's Association, April 24, 2024. [Online]. Available: https://www.statista.com/statistics/1173714/alzheimer-disease-therapies-in-phase-ii-by-type/
